Reperfusion in STEMI patients: still a role for cardioprotection?

Area of Science:

• Cardiology
• Cardiovascular Research
• Medical Science

Background:

• Ischemic heart disease is a leading global cause of death.
• ST-elevation myocardial infarction (STEMI) mortality has decreased, yet remains a concern.
• Reperfusion therapy, while effective, can cause additional myocardial injury (ischemia/reperfusion injury, IRI).

Purpose of the Study:

• To highlight the significance of infarct size (IS) as a determinant of mortality and heart failure post-STEMI.
• To underscore the challenges posed by IRI and coronary microvascular dysfunction in reperfusion therapy.
• To identify the need for novel cardioprotective strategies in STEMI management.

Main Methods:

• Review of patient-level meta-analysis data.
• Analysis of factors influencing infarct size after primary percutaneous coronary intervention (PPCI).
• Evaluation of the impact of reperfusion on myocardial injury and coronary microcirculation.

Main Results:

• Infarct size within one month post-PPCI is a critical predictor of 1-year all-cause mortality and heart failure hospitalization.
• Reperfusion, though necessary, contributes to myocardial injury and final infarct size.
• Coronary microvascular dysfunction presents a significant barrier to effective myocardial reperfusion.

Conclusions:

• Reducing infarct size is paramount for improving outcomes after STEMI.
• Addressing ischemia/reperfusion injury and coronary microvascular dysfunction is the next frontier in reperfusion therapy.
• Development of additional cardioprotective strategies is essential for optimizing STEMI treatment.